The nephrostomy devices market size is estimated to be USD 1062.5 million in 2022 and is expected to witness a CAGR of 9.74% during the forecast period 2023-2033. The rise in popularity of minimally invasive procedures, surging incidences of diseases linked to a particular lifestyle, and the development of healthcare infrastructure in emerging nations are projected to drive market growth in the near future. However, rising rates of prostate, ovarian, and bladder cancer, and an increase in hydronephroses are predicted to limit market growth are expected to restrain market growth.

Segmentation

By Products

On the basis of products, the market is segregated into nephrostomy catheters and guidewires. In 2022, the guidewires segment held the highest market share owing to the demand for the product being anticipated to rise as a result of the aging population and the development of bladder and urogenital problems, and the product’s less invasive features.

By End User

On the basis of end user, the market is categorized into hospitals and ASCs. In 2022, the ASCs, hospitals & clinics, specialty clinics segment held the highest market share owing to the superior results in comparison to hospitals and other healthcare facilities.

Regional Markets

In 2022, North America region accounted for the highest revenue in the nephrostomy devices market and is expected to maintain its dominance during the forecast period. This is attributed to availability of trained medical professionals, rising consumer understanding of the product, and the area’s accessibility to reputable healthcare facilities. However, the Asia-Pacific region is predicted to grow at the fastest rate during the projection period owing to growing kidney disease incidence, encouraging government actions, and several NGOs’ campaigns to spread the word about the product, and the industry is expanding as a result of the presence of numerous important enterprises in China and India.

Competitor Insights

Some of the key players operating in the nephrostomy devices market are B. Braun Melsungen AG (Germany), BD (US), Boston Scientific Corporation (US), Electramed Ltd. (Ireland), Medi-Globe GmbH (Germany), Olympus Corporation (Japan), Straub Medical AG (Switzerland), SURU International Pvt. Ltd (India), Teleflex Incorporated (US), and UreSil LLC (US).

This comprehensive research report focuses on the global and regional market size and forecasts of diverse segments including product and end user from 2022 to 2033.

Report Scope:

Segmentation: Nephrostomy Devices Market Report 2022 – 2033

Products (Revenue, USD Million), 2022 – 2033

• Sheath Dilators
• Nephrostomy Catheters
• Drainage Tubes
• Guidewires
• Others

End User (Revenue, USD Million), 2022 – 2033

• Ambulatory Surgical Centers (ASCs)
• Hospitals
• Emergency Clinics
• Specialty Clinics

By Region (Revenue, USD Million), 2022 – 2033

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of MEA